Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
U.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.373NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.373NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.373NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.80NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.80NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.80NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.433NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.433NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.433NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.36.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.36.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.36.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AN.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AN.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.221.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.221.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.221.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.242NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.242NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.242NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.160.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.449NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.449NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.449NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.152NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.152NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.152NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.146NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.146NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.146NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
D.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
D.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
D.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.81NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.81NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.81NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.258.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.258.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.160.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used